Search 

Karma Oncology is a specialised oncology clinical development company headquartered in Scotland with offices in Netherlands and USA.  We offer a complete range of development services from clinical development planning, protocol design and authoring, strategic country/site selection, regulatory submissions, through to clinical trial execution and reporting. 

Adaptable - We can provide selected individual services, and extend to full-service global CRO capabilities clients require.  Our size allows us to be flexible, innovative and responsive to individual sponsor requirements and to adhere strictly to sponsor specified development timelines.

Reliable - Our Project Managers have extensive oncology experience, our monitors are professional, mature 'career' CRAs - not trainees - and we have the lowest staff turnover in the industry (<5%).  Many of our staff come from a nursing or medical background, and for international studies we use CRAs native to their country.

Motivated - Our team has successfully completed programs in a broad range of solid tumour and hematologic indications utilising an array of different therapeutic approaches including immunotherapy and cell therapies (autologous, CAR-T and CAR-NK).

Accountable – The Karma team focus on delivering quality while respecting sponsor timelines (not internal timelines) and will do what it takes to do so.

Twitter Account @KarmaOncology

We are the Clinical Research Network (CRN) part of the National Institute for Health Research (NIHR). From feasibility, to site selection, to monitoring recruitment. We provide the life sciences industry with a flexible package of free support to help plan, place and successfully deliver clinical research in the UK to time and target. We do this by working in partnership with the NHS and social care providers to deliver high quality commercial clinical research. Our dedicated, research-ready workforce of 10,000+ personnel is embedded throughout our health and care services in England. Our support is available to all life science industries regardless of location, study type, study size, or therapy area.